Company: IMCR
Filing Date: 2025-01-10
Form Type: 8-K
Source: 0001140361-25-000837
Chunk: 0

Company: Immunocore Holdings plc
Filing Date: 2025-01-10
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02.      Results of Operations and Financial Condition.  

On January 10, 2025, Immunocore Holdings plc (the “ Company”) announced a preliminary estimate of the amount of its cash and cash
equivalents at December 31, 2024. The Company preliminarily estimates that its cash and cash equivalents as of December 31, 2024 were approximately $820 million.

The information in this Item 2.02 is preliminary, has not been audited and is subject to change pending completion of the Company’s
audited financial statements for the year ended December 31, 2024. It is possible that the Company or its independent registered public accounting firm may identify items that require the Company to make adjustments to the amounts included in this
Item 2.02, and such changes could be material. Additional information and disclosures would also be required for a more complete understanding of the Company’s financial position and results of operations as of December 31, 2024.